Further Standardization And Phase I Clinical Trials Of Immune Booster/Anti-Inefective For Prevention And Management Of Viral Infection Including Covid-19 (Nnmda'S Koviron)
Further Standardization And Phase I Clinical Trials Of Immune Booster/Anti-Inefective For Prevention And Management Of Viral Infection Including Covid-19 (Nnmda'S Koviron)
-
eyemarked
-
REVIEWS
-
AVG. SENTIMENT
Further Standardization And Phase I Clinical Trials Of Immune Booster/Anti-Inefective For Prevention And Management Of Viral Infection Including Covid...
Last Modified: 31/07/2026, 16:11
Description
Below explains what this project is all about.
Further Standardization And Phase I Clinical Trials Of Immune Booster/Anti-Inefective For Prevention And Management Of Viral Infection Including Covid-19 (Nnmda'S Koviron) with a project code of ERGP30174278 under FEDERAL MINISTRY OF SCIENCE, TECHNOLOGY AND INNOVATION is currently domiciled in NIGERIA NATURAL MEDICINE DEVELOPMENT AGENCY with a total appropriation of N53662094.00 and an annual appropriation of N53662094.0 in 2022 .The project is currently NOT STARTED.
Contractors (0)
No contractors assigned.
Locations (0)
No locations indicated
Unfortunately, there are no locations to display for this project at the moment.
Comments
No comments yet
Comments on this project will appear here
Citizen Review
General Sentiment
No sentiment data
No reviews yet
General Information
New to ,Eyemark,?
Sign up now to keep projects within your supervision!
By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.